Lawson Health Research Institute, Canadian Research & Development Centre for Probiotics, London N6A 4V2 Ontario, Canada.
Benef Microbes. 2011 Sep;2(3):177-81. doi: 10.3920/BM2011.0026.
In times when human life and quality of life remain threatened by infectious diseases, increasing microbial resistance and a diminished armamentarium of treatments, you might think that the European Commission would urgently seek and encourage alternative approaches. On the contrary, the European Food Safety Authority (EFSA) has created a panel that has ignored good science, over-ridden peer-reviewed medical studies, and seems intent on breaking the back of a validated approach to infectious disease management, namely probiotics. The recent rejection of a simple and quite bland claim related to vaginal health emphasises the travesty of this bureaucracy. Herein, the science fights back and counters the critique of EFSA.
在人类生命和生活质量仍然受到传染病、微生物耐药性增加和治疗手段减少的威胁的时代，你可能会认为欧盟委员会会紧急寻求并鼓励替代方法。但恰恰相反，欧洲食品安全局 (EFSA) 成立了一个小组，该小组无视良好的科学，推翻了同行评审的医学研究，似乎有意破坏一种经过验证的传染病管理方法，即益生菌。最近对与阴道健康相关的一个简单而平淡的声明的否决强调了这种官僚主义的荒诞。在这里，科学进行了反击，反驳了对 EFSA 的批评。
